1. Home
  2. ATCH vs HOWL Comparison

ATCH vs HOWL Comparison

Compare ATCH & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.24

Market Cap

34.9M

Sector

N/A

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.65

Market Cap

29.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATCH
HOWL
Founded
2022
2017
Country
United States
United States
Employees
43
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.9M
29.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ATCH
HOWL
Price
$0.24
$0.65
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
6.9M
423.0K
Earning Date
02-13-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$14,613,715.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.72
N/A
Revenue Growth
52.99
N/A
52 Week Low
$0.14
$0.53
52 Week High
$13.19
$2.38

Technical Indicators

Market Signals
Indicator
ATCH
HOWL
Relative Strength Index (RSI) 44.31 47.35
Support Level $0.23 $0.59
Resistance Level $0.28 $0.74
Average True Range (ATR) 0.02 0.07
MACD 0.00 0.01
Stochastic Oscillator 28.52 29.72

Price Performance

Historical Comparison
ATCH
HOWL

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: